Get started
Work

Supplementary Figure 1 from NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors

Year: 2023
Type: supplementary-materials
Abstract: Trial profile for enrolled patients.
DOI: 10.1158/2767-9764.23579973.v1
Authors: Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A. Boerner, Diane E. Durecki, Joseph P. Eder, Kurt A. Schalper, Alice P. Chen, Patricia LoRusso
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4382021435
Cites:
Cited by:
Related to: 10